Associate Professor of Oncology Head and Neck Tumor Group, Mayo Clinic Rochester, Minnesota, United States
Disclosure(s):
Katharine A. Price, MD: No financial relationships to disclose
Presentation Description / Summary: Drawing on years of treating and managing human patients with head and neck cancer on PD-1 checkpoint inhibitors, Dr. Price will review the mechanism and use of PD-1 agents and provide practical recommendations for treating and monitoring patients and the management of immune-related toxicities.
Learner Outcomes: TBD
Learning Objectives:
Upon completion, participant will be able to demonstrate understanding of thee mechanism of action of PD-1 checkpoint inhibitor immunotherapy.
Upon completion, participant will be able to list common immunotherapy-related toxicities and how to monitor for them.
Upon completion, participant will be able to describe how to manage common immunotherapy-related toxicities.
